Thermedical announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application for the Early Feasibility Study (EFS) of the company’s Durablate ablation catheter. The single-arm, observational study is designed to evaluate the safety and effectiveness of the Durablate catheter to treat ventricular tachycardia (VT), a leading cause of sudden cardiac death in the United States.

Medical imaging has become the bellwether for the application of artificial intelligence (AI) technologies, especially deep learning techniques in the healthcare space, according to a new report from industry analysts Frost & Sullivan. The report, “Artificial Intelligence for Medical Image Analysis—Companies-to-Action, 2018,” indicates that more than 90 companies are at various stages of development and commercialization of AI-based solutions for the medical imaging industry.

July 30, 2018 — Approximately 75 percent of black and men women are likely to develop high blood pressure by the age of ...

The number of patients undergoing mitral valve operations are at an all-time high, and new research suggests many patients do not undergo surgical intervention until it is too late to completely reverse damage caused by mitral valve disease. The study is posted online in The Annals of Thoracic Surgery.

July 26, 2018 — The Society of Cardiac Angiography and Interventions (SCAI) released a focused update expert consensus ...